Back Symax™ Duotab

Contact

Please complete the form below.

Contact

First Name*
Last Name*
Email*

Address

Address
Address 2
Town/City
State ZIP

Would you like a sales representative to call you?

Yes No

Are you an:

MD DO Other

Symax™ Duotab is contraindicated in patients with glaucoma, obstructive uropathy, obstructive diseases of the gastrointestinal tract, paralytic ileum, intestinal atony of elderly or debilitated patients, unstable cardiovascular status, severe ulcerative colitis, toxic megacolon, myasthenia gravis, and myocardial ischemia.

Not recommended for use in children under 2 years of age.

Click here to download the package insert for complete Prescribing Information.

References:

1. Symax™ Duotab [package insert]. Fort Worth, Tex: Capellon Pharmaceuticals, Ltd; 2005.

2. Data on file: DOF-SMX-001. Capellon Pharmaceuticals, Ltd.

Symax is a trademark of Capellon Pharmaceuticals, Ltd. U.S. Patent Pending No. 10/879,506

©2006 StoneBridge Pharma, LLC. 03.06.06

www.stonebridgepharma.com

Capellon Pharmaceuticals, Ltd.
Fort Worth, TX 76118

StoneBridge Pharma, LLC.
Duluth, GA 30097